Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T14:06:34.394Z.
Calculation as of: 2026-10-06T14:06:34.394Z.
Quote observation: 2026-10-06T14:05:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Freedom Metals Acquisition Corp.
Market Cap
$271.15M
EV/EBITDA Ratio
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO |
|---|---|---|
| Freedom Metals Acquisition Corp. (FDMM) | $271.15M | N/A |
| Cartesian Growth Corp. Iv (CGCF)vs › | $270.05M | N/A |
| Kingstone Companies, Inc. (KINS)vs › | $270.07M | N/A |
| LCNB Corp. (LCNB)vs › | $275.66M | N/A |
| First National Corporation (FXNC)vs › | $274.84M | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $267.13M | N/A |
| Isabella Bank Corporation (ISBA)vs › | $275.56M | N/A |
| Medallion Financial Corp. (MFIN)vs › | $277.12M | N/A |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $265.26M | N/A |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
